This brand name is authorized in Australia, Canada, France, Netherlands
The drug ANANDRON contains one active pharmaceutical ingredient (API):
|
1
Nilutamide
UNII 51G6I8B902 - NILUTAMIDE
|
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| L02BB02 | Nilutamide | L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02B Hormone antagonists and related agents → L02BB Anti-androgens |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 8131Y |
| Country: CA | Health Products and Food Branch | Identifier(s): 02221861 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 67541333, 69060099 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 45063 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
